MDS Podcast Dystonia Series: Pearls on diagnosis and phenomenology
In part 1 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Miryam Carecchio on pearls on diagnosis and phenomenology of dystonic syndrome.
Stay up to date on novel, clinically-relevant research findings in Parkinson’s disease and other movement disorders.
All Episodes
MDS Podcast Idiopathic Normal Pressure Hydrocephalus: Critical Review of Objective Findings
Prof Martino points out the existent literature concerning the objective findings in the 3 cardinal domains of idiopathic normal pressure hydrocephalus. Read the article.
MDS Podcast History of Movement Disorders: Huntington’s Disease in Venezuela
As part of the History of Movement Disorders series, Dr. Sara Schaefer and Dr. David Standaert discuss the research and humanitarian work by Nancy Wexler and team starting in...
MDS Podcast Deep brain stimulation for Parkinson’s disease dementia: are we there yet?
Dr. Michele Matarazzo interviews Prof. Marjan Jahanshahi on the long term results of the clinical trial of deep brain stimulation of the nucleus basalis of Meynert in people with...
MDS Podcast The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders
In this episode, Dr. Hugo Morales Briceño discusses the spectrum of phenotypes and genotypes of children with hyperkinetic movement disorders with Dr. Belén Pérez Dueñas and Prof. Manju Kurian....
MDS Podcast Can dogs diagnose Parkinson’s disease?
Dr. Sarah Lidstone interviews Dr. Chang-Qing Gao & Prof. Ji-fung Guo about their recent research on the sensitivity of sniffer dogs for diagnosing Parkinson’s disease. Read the article.
MDS Podcast Nosology and Cut-Off Values for Axial Postural Abnormalities in Parkinsonism
Members of the task force for Axial Postural Abnormalities in Parkinsonism, Prof. Tinazzi, Dr. Geroin and Dr. Artusi, discuss new nosology and cut-off values. Read the article.
MDS Podcast COVID-19 and the Risk of Parkinsonism
Dr. Sara Schaefer discusses with Prof. Richard Smeyne how viruses including COVID-19 increase the susceptibility to oxidative stress-induced parkinsonism in mouse models, the historical evidence to support a virus-parkinsonism...